Antigen Detection Assay for Tuberculosis

Information

  • Research Project
  • 7157546
  • ApplicationId
    7157546
  • Core Project Number
    R41AI068291
  • Full Project Number
    1R41AI068291-01A1
  • Serial Number
    68291
  • FOA Number
    PA-06-06
  • Sub Project Id
  • Project Start Date
    9/1/2006 - 19 years ago
  • Project End Date
    8/31/2008 - 17 years ago
  • Program Officer Name
    JACOBS, GAIL G.
  • Budget Start Date
    9/1/2006 - 19 years ago
  • Budget End Date
    8/31/2008 - 17 years ago
  • Fiscal Year
    2006
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    9/1/2006 - 19 years ago

Antigen Detection Assay for Tuberculosis

[unreadable] DESCRIPTION (provided by applicant): Antigen detection assay in contrast to conventional serological test, detects disease status and not the host antibody response to the disease etiological agent. It can therefore, be used for both diagnosis and disease treatment follow-up purposes. Antigen detection assay has recently been successfully introduced for the diagnosis of different infectious diseases including hepatitis, pneumonia caused by Streptococcus pneumoniae or Legionella pneumophilla, sore throat cause by Streptococcus pyogenes, and amoebiasis. Although antigen detection assay has the potential to discriminate latent from adult tuberculosis, paradoxically this test has not yet been developed for this disease. Using the ultra-sensitive mass spectrometry technology we have recently described the presence of M. tuberculosis proteins in urine of infected mice. The proteins were sequenced, the encoding genes were cloned, and the recombinant proteins were obtained. 1 such molecule revealed to be a promising tool for the diagnosis of tuberculosis. Using similar approach we have recently identified M. tuberculosis antigens in urine of human patients with pulmonary tuberculosis. The present project aims to produce the corresponding recombinant proteins and use them as well as the ones previously described in mouse model to develop antigen detection assays for the diagnosis of tuberculosis disease. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R41
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    386997
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
    NIAID:386997\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    INBIOS INTERNATIONAL, INC.
  • Organization Department
  • Organization DUNS
    004006628
  • Organization City
    SEATTLE
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    98104
  • Organization District
    UNITED STATES